๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparison of end-user computing characteristics in the U.S., Israel and Taiwan

โœ Scribed by Magid Igbaria; Moshe Zviran

Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
976 KB
Volume
30
Category
Article
ISSN
0378-7206

No coin nor oath required. For personal study only.

โœฆ Synopsis

This study examines the effect of national environments on end-user computing characteristics. Data were collected from American, Israeli, and Taiwanese companies. The participants were 156 U.S., 138 Israeli, and 86 end-users from Taiwan, all holding managerial positions in the financial industry. The results clearly demonstrate the existence of cultural differences among the three samples in terms of adaption and usage characteristics. Conclusions are drawn to guide management action; they emphasize the need for cross-cultural studies in the information systems field in general and in end-user computing in particular.

๐Ÿ“œ SIMILAR VOLUMES

A laboratory study of user characteristi
A laboratory study of user characteristics and decision-making performance in end-user computing
โœ George M. Kasper; Robert P. Cerveny ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 855 KB

A laboratory study using a simulated business setting was conducted to examine relationships among user characteristics, DSS usage patterns. and decision-making performance. MBAstudent subjects self-selected into one of two categories: (1) "end-user programmers" who chose to use the DSS modeling l

The results of prostate carcinoma screen
The results of prostate carcinoma screening in the U. S. As reflected in the surveillance, epidemiology, and end results program
โœ Charles R. Smart ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 211 KB ๐Ÿ‘ 1 views

## Background: The rapid escalation in the incidence of prostate carcinoma between the years 1988 and 1992 has been attributed to prostate specific antigen screening. there have been concerns regarding the possible diagnosis and treatment of insignificant tumors in the absence of randomized, contro